Theme: Early diagnosis, treatment of viral hepatitis and optimizing therapy costs

Hepatitis 2017

Hepatitis 2017

Sessions/Tracks

Track 1: Hepatitis B

Hepatitis B is a liver infection caused by the Hepatitis B virus (HBV). HBV is transmitted through activities that involve percutaneous or mucosal contact with infectious blood or body fluids. HBV can survive outside the body at least 7 days and still be capable of causing infection. The best way to prevent hepatitis B is by getting the hepatitis B vaccine. The pathogenesis and clinical manifestations of hepatitis B are due to the interaction of the virus and the host immune system, which lead to liver injury and potentially cirrhosis and hepatocellular carcinoma. Patients can have either an acute symptomatic disease or an asymptomatic disease.

Related  Hepatitis Conferences | Liver Conferences | Conference Series LLC: International Conference on Pancreatic Disorders and Treatment, October 17-19, 2016 Chicago, USA; 9 th Euro-Global Gastroenterology Conference, October 24-25, 2016 Valencia, Spain; International Conference on Digestive Diseases, December 08-09, 2016 Dubai, UAE; 4th International Conference on Hepatology, April 27-29, 2017 Dubai, UAE; 11th Global Gastroenterologists Meeting, June 12-13, 2017 Rome, Italy; 5th World Congress on Hepatitis & Liver Diseases, August 10-12, 2017 London, UK; 13th International Conference on Clinical Gastroenterology and Hepatology, November 13-15, 2017 Las Vegas, USA; Asian Pacific Digestive Week, November 02-05, 2016 Kobe, Japan; Japan Digestive Disease Week, November 03-06, 2016 Kobe, Japan; Seoul International Digestive Disease Symposium, November 24-25, 2016 South Korea; 57th Annual Conference of Indian Society of Gastroenterology, December 15-18, 2016 New Delhi, India; Gastrointestinal Cancers Symposium, January 19 – 21, 2017 San Francisco, USA;  Institute of Liver Diseases and Transplantation, January 20-22, 2017 Tamil Nadu, India; 10th Paris Hepatitis Conference, January 30-31, 2017 Paris, France; EASL HCC Summit, February 2-5, 2017 Geneva, Switzerland; EASL Liver Immunology, February 16-18, 2017 Aachen, Germany; Asian Pacific Association for the Study of the Liver, February 16-19, 2017 Shanghai, China; 6th Canadian Symposium on HCV, March 03, 2017 Banff, Canada; 17th Annual Gastroenterology and Hepatology, March 7-10, 2017 San Juan, Puerto Rico; Mayo Clinic Gastroenterology and Hepatology, March 16-19 2017 Orlando, USA; World Hepatitis Summit, March 29-31, 2017 São Paulo, Brazil; Congress of the Italian Society of Digestive Diseases, March 29-April 1, 2017 Bologna, Italy; World Congress of the International Hepato-Pancreato-Biliary Association, March 29-April 2, 2017 Miami, USA; European Gastro Update, April 7-8, 2017 Vienna, Austria; The International Liver Congress, April 19-23, 2017 Amsterdam, Netherlands;  6th Asian Conference on Hepatitis and AIDS, May 20-21, 2017 Tianjin, China; 15th European Meeting on HIV & Hepatitis – Treatment Strategies & Antiviral Drug Resistance, June 7-9, 2017 Rome, Italy; 3rd Central & Eastern Meeting on Viral Hepatitis and Co-infection with HIV, October 6-7, 2017 Bucharest, Romania; World Congress on Gastroenterology, October 13-18, 2017 Florida, USA; International HBV Cure Workshop, November 10, 2017 Toronto, Canada; 4th International Meeting on Elimination of Viral Hepatitis, December 1-2, 2017 Amsterdam, Netherlands; American Association for the Study of Liver DiseasesAmerican Hepato-Pancreato-Biliary AssociationAmerican Liver FoundationEuropean Association for the Study of the LiverAsian Pacific Association for the Study of the LiverInternational Association for the Study of the LiverBritish Association for the Study of the LiverCanadian Association for the Study of the LiverCanadian Liver FoundationChildren's Liver Disease FoundationEuroliver FoundationHepatitis B FoundationHepatitis Foundation InternationalInternational Liver Transplantation SocietyInternational Hepato Pancreato Biliary Association      

Track 2: Hepatitis C

Hepatitis C is a devastating viral disease that generally progresses slowly, meaning patients often remain asymptomatic and unaware they are infected until very serious and often expensive complications emerge as a result of damage to the liver. It is estimated that about half of those infected are not aware that they carry the virus. The recent remarkable advances in treating hepatitis C built on incremental improvements achieved over the previous two decades to transform hepatitis C from a chronic, fatal disease, to an infection that with new and forthcoming treatments, can be potentially cured.

Related  Hepatitis Conferences | Liver Conferences | Conference Series LLC: International Conference on Pancreatic Disorders and Treatment, October 17-19, 2016 Chicago, USA; 9 th Euro-Global Gastroenterology Conference, October 24-25, 2016 Valencia, Spain; International Conference on Digestive Diseases, December 08-09, 2016 Dubai, UAE; 4th International Conference on Hepatology, April 27-29, 2017 Dubai, UAE; 11th Global Gastroenterologists Meeting, June 12-13, 2017 Rome, Italy; 5th World Congress on Hepatitis & Liver Diseases, August 10-12, 2017 London, UK; 13th International Conference on Clinical Gastroenterology and Hepatology, November 13-15, 2017 Las Vegas, USA; Asian Pacific Digestive Week, November 02-05, 2016 Kobe, Japan; Japan Digestive Disease Week, November 03-06, 2016 Kobe, Japan; Seoul International Digestive Disease Symposium, November 24-25, 2016 South Korea; 57th Annual Conference of Indian Society of Gastroenterology, December 15-18, 2016 New Delhi, India; Gastrointestinal Cancers Symposium, January 19 – 21, 2017 San Francisco, USA;  Institute of Liver Diseases and Transplantation, January 20-22, 2017 Tamil Nadu, India; 10th Paris Hepatitis Conference, January 30-31, 2017 Paris, France; EASL HCC Summit, February 2-5, 2017 Geneva, Switzerland; EASL Liver Immunology, February 16-18, 2017 Aachen, Germany; Asian Pacific Association for the Study of the Liver, February 16-19, 2017 Shanghai, China; 6th Canadian Symposium on HCV, March 03, 2017 Banff, Canada; 17th Annual Gastroenterology and Hepatology, March 7-10, 2017 San Juan, Puerto Rico; Mayo Clinic Gastroenterology and Hepatology, March 16-19 2017 Orlando, USA; World Hepatitis Summit, March 29-31, 2017 São Paulo, Brazil; Congress of the Italian Society of Digestive Diseases, March 29-April 1, 2017 Bologna, Italy; World Congress of the International Hepato-Pancreato-Biliary Association, March 29-April 2, 2017 Miami, USA; European Gastro Update, April 7-8, 2017 Vienna, Austria; The International Liver Congress, April 19-23, 2017 Amsterdam, Netherlands;  6th Asian Conference on Hepatitis and AIDS, May 20-21, 2017 Tianjin, China; 15th European Meeting on HIV & Hepatitis – Treatment Strategies & Antiviral Drug Resistance, June 7-9, 2017 Rome, Italy; 3rd Central & Eastern Meeting on Viral Hepatitis and Co-infection with HIV, October 6-7, 2017 Bucharest, Romania; World Congress on Gastroenterology, October 13-18, 2017 Florida, USA; International HBV Cure Workshop, November 10, 2017 Toronto, Canada; 4th International Meeting on Elimination of Viral Hepatitis, December 1-2, 2017 Amsterdam, Netherlands; American Association for the Study of Liver DiseasesAmerican Hepato-Pancreato-Biliary AssociationAmerican Liver FoundationEuropean Association for the Study of the LiverAsian Pacific Association for the Study of the LiverInternational Association for the Study of the LiverBritish Association for the Study of the LiverCanadian Association for the Study of the LiverCanadian Liver FoundationChildren's Liver Disease FoundationEuroliver FoundationHepatitis B FoundationHepatitis Foundation InternationalInternational Liver Transplantation SocietyInternational Hepato Pancreato Biliary Association
   

Track 3: Non-Viral Hepatitis

Non-viral hepatitis is an inflammation of the liver caused by toxins, drugs, or other harmful chemicals that destroy cells in the liver (Hepatocytes).  Acute hepatitis damages hepatocytes, make up 70-85% of the total mass of the liver. The disease is a growing problem due to the increasing number of dietary supplements with liver side effects. If hepatitis leads to liver failure, a liver transplant is the only treatment option that can improve survival.

Related  Hepatitis Conferences | Liver Conferences | Conference Series LLC: International Conference on Pancreatic Disorders and Treatment, October 17-19, 2016 Chicago, USA; 9 th Euro-Global Gastroenterology Conference, October 24-25, 2016 Valencia, Spain; International Conference on Digestive Diseases, December 08-09, 2016 Dubai, UAE; 4th International Conference on Hepatology, April 27-29, 2017 Dubai, UAE; 11th Global Gastroenterologists Meeting, June 12-13, 2017 Rome, Italy; 5th World Congress on Hepatitis & Liver Diseases, August 10-12, 2017 London, UK; 13th International Conference on Clinical Gastroenterology and Hepatology, November 13-15, 2017 Las Vegas, USA; Asian Pacific Digestive Week, November 02-05, 2016 Kobe, Japan; Japan Digestive Disease Week, November 03-06, 2016 Kobe, Japan; Seoul International Digestive Disease Symposium, November 24-25, 2016 South Korea; 57th Annual Conference of Indian Society of Gastroenterology, December 15-18, 2016 New Delhi, India; Gastrointestinal Cancers Symposium, January 19 – 21, 2017 San Francisco, USA;  Institute of Liver Diseases and Transplantation, January 20-22, 2017 Tamil Nadu, India; 10th Paris Hepatitis Conference, January 30-31, 2017 Paris, France; EASL HCC Summit, February 2-5, 2017 Geneva, Switzerland; EASL Liver Immunology, February 16-18, 2017 Aachen, Germany; Asian Pacific Association for the Study of the Liver, February 16-19, 2017 Shanghai, China; 6th Canadian Symposium on HCV, March 03, 2017 Banff, Canada; 17th Annual Gastroenterology and Hepatology, March 7-10, 2017 San Juan, Puerto Rico; Mayo Clinic Gastroenterology and Hepatology, March 16-19 2017 Orlando, USA; World Hepatitis Summit, March 29-31, 2017 São Paulo, Brazil; Congress of the Italian Society of Digestive Diseases, March 29-April 1, 2017 Bologna, Italy; World Congress of the International Hepato-Pancreato-Biliary Association, March 29-April 2, 2017 Miami, USA; European Gastro Update, April 7-8, 2017 Vienna, Austria; The International Liver Congress, April 19-23, 2017 Amsterdam, Netherlands;  6th Asian Conference on Hepatitis and AIDS, May 20-21, 2017 Tianjin, China; 15th European Meeting on HIV & Hepatitis – Treatment Strategies & Antiviral Drug Resistance, June 7-9, 2017 Rome, Italy; 3rd Central & Eastern Meeting on Viral Hepatitis and Co-infection with HIV, October 6-7, 2017 Bucharest, Romania; World Congress on Gastroenterology, October 13-18, 2017 Florida, USA; International HBV Cure Workshop, November 10, 2017 Toronto, Canada; 4th International Meeting on Elimination of Viral Hepatitis, December 1-2, 2017 Amsterdam, Netherlands; American Association for the Study of Liver DiseasesAmerican Hepato-Pancreato-Biliary AssociationAmerican Liver FoundationEuropean Association for the Study of the LiverAsian Pacific Association for the Study of the LiverInternational Association for the Study of the LiverBritish Association for the Study of the LiverCanadian Association for the Study of the LiverCanadian Liver FoundationChildren's Liver Disease FoundationEuroliver FoundationHepatitis B FoundationHepatitis Foundation InternationalInternational Liver Transplantation SocietyInternational Hepato Pancreato Biliary Association
 

Track 4: Hepatitis Vaccination

The best way to prevent hepatitis is by getting the hepatitis vaccines. Vaccination is safe and effective and it is recommended for all. Efforts to develop a hepatitis C vaccine started more than 20 years ago, when the hepatitis C virus was identified. The hepatitis C virus is more variable than are the viruses that cause hepatitis A and hepatitis B. Hepatitis C virus occurs in at least six genetically distinct forms with 50 subtypes. A global vaccine would have to protect against all these variants of the virus.

Related  Hepatitis Conferences | Liver Conferences | Conference Series LLC: International Conference on Pancreatic Disorders and Treatment, October 17-19, 2016 Chicago, USA; 9 th Euro-Global Gastroenterology Conference, October 24-25, 2016 Valencia, Spain; International Conference on Digestive Diseases, December 08-09, 2016 Dubai, UAE; 4th International Conference on Hepatology, April 27-29, 2017 Dubai, UAE; 11th Global Gastroenterologists Meeting, June 12-13, 2017 Rome, Italy; 5th World Congress on Hepatitis & Liver Diseases, August 10-12, 2017 London, UK; 13th International Conference on Clinical Gastroenterology and Hepatology, November 13-15, 2017 Las Vegas, USA; Asian Pacific Digestive Week, November 02-05, 2016 Kobe, Japan; Japan Digestive Disease Week, November 03-06, 2016 Kobe, Japan; Seoul International Digestive Disease Symposium, November 24-25, 2016 South Korea; 57th Annual Conference of Indian Society of Gastroenterology, December 15-18, 2016 New Delhi, India; Gastrointestinal Cancers Symposium, January 19 – 21, 2017 San Francisco, USA;  Institute of Liver Diseases and Transplantation, January 20-22, 2017 Tamil Nadu, India; 10th Paris Hepatitis Conference, January 30-31, 2017 Paris, France; EASL HCC Summit, February 2-5, 2017 Geneva, Switzerland; EASL Liver Immunology, February 16-18, 2017 Aachen, Germany; Asian Pacific Association for the Study of the Liver, February 16-19, 2017 Shanghai, China; 6th Canadian Symposium on HCV, March 03, 2017 Banff, Canada; 17th Annual Gastroenterology and Hepatology, March 7-10, 2017 San Juan, Puerto Rico; Mayo Clinic Gastroenterology and Hepatology, March 16-19 2017 Orlando, USA; World Hepatitis Summit, March 29-31, 2017 São Paulo, Brazil; Congress of the Italian Society of Digestive Diseases, March 29-April 1, 2017 Bologna, Italy; World Congress of the International Hepato-Pancreato-Biliary Association, March 29-April 2, 2017 Miami, USA; European Gastro Update, April 7-8, 2017 Vienna, Austria; The International Liver Congress, April 19-23, 2017 Amsterdam, Netherlands;  6th Asian Conference on Hepatitis and AIDS, May 20-21, 2017 Tianjin, China; 15th European Meeting on HIV & Hepatitis – Treatment Strategies & Antiviral Drug Resistance, June 7-9, 2017 Rome, Italy; 3rd Central & Eastern Meeting on Viral Hepatitis and Co-infection with HIV, October 6-7, 2017 Bucharest, Romania; World Congress on Gastroenterology, October 13-18, 2017 Florida, USA; International HBV Cure Workshop, November 10, 2017 Toronto, Canada; 4th International Meeting on Elimination of Viral Hepatitis, December 1-2, 2017 Amsterdam, Netherlands; American Association for the Study of Liver DiseasesAmerican Hepato-Pancreato-Biliary AssociationAmerican Liver FoundationEuropean Association for the Study of the LiverAsian Pacific Association for the Study of the LiverInternational Association for the Study of the LiverBritish Association for the Study of the LiverCanadian Association for the Study of the LiverCanadian Liver FoundationChildren's Liver Disease FoundationEuroliver FoundationHepatitis B FoundationHepatitis Foundation InternationalInternational Liver Transplantation SocietyInternational Hepato Pancreato Biliary Association
      

Track 5: Hepatocellular Carcinoma

Hepatocellular carcinoma accounts for most liver cancers. This type of liver cancer occurs more often in men than women and is usually seen in people age 50 or older. It is commonly associated with cirrhosis and hepatitis. The incidence of hepatocellular carcinoma is highest in Asia and Africa, where the endemic high prevalence of hepatitis B and hepatitis C strongly predisposes to the development of chronic liver disease and subsequent development of hepatocellular carcinoma. Other risk factors can include a history of alcohol abuse.

Related  Hepatitis Conferences | Liver Conferences | Conference Series LLC: International Conference on Pancreatic Disorders and Treatment, October 17-19, 2016 Chicago, USA; 9 th Euro-Global Gastroenterology Conference, October 24-25, 2016 Valencia, Spain; International Conference on Digestive Diseases, December 08-09, 2016 Dubai, UAE; 4th International Conference on Hepatology, April 27-29, 2017 Dubai, UAE; 11th Global Gastroenterologists Meeting, June 12-13, 2017 Rome, Italy; 5th World Congress on Hepatitis & Liver Diseases, August 10-12, 2017 London, UK; 13th International Conference on Clinical Gastroenterology and Hepatology, November 13-15, 2017 Las Vegas, USA; Asian Pacific Digestive Week, November 02-05, 2016 Kobe, Japan; Japan Digestive Disease Week, November 03-06, 2016 Kobe, Japan; Seoul International Digestive Disease Symposium, November 24-25, 2016 South Korea; 57th Annual Conference of Indian Society of Gastroenterology, December 15-18, 2016 New Delhi, India; Gastrointestinal Cancers Symposium, January 19 – 21, 2017 San Francisco, USA;  Institute of Liver Diseases and Transplantation, January 20-22, 2017 Tamil Nadu, India; 10th Paris Hepatitis Conference, January 30-31, 2017 Paris, France; EASL HCC Summit, February 2-5, 2017 Geneva, Switzerland; EASL Liver Immunology, February 16-18, 2017 Aachen, Germany; Asian Pacific Association for the Study of the Liver, February 16-19, 2017 Shanghai, China; 6th Canadian Symposium on HCV, March 03, 2017 Banff, Canada; 17th Annual Gastroenterology and Hepatology, March 7-10, 2017 San Juan, Puerto Rico; Mayo Clinic Gastroenterology and Hepatology, March 16-19 2017 Orlando, USA; World Hepatitis Summit, March 29-31, 2017 São Paulo, Brazil; Congress of the Italian Society of Digestive Diseases, March 29-April 1, 2017 Bologna, Italy; World Congress of the International Hepato-Pancreato-Biliary Association, March 29-April 2, 2017 Miami, USA; European Gastro Update, April 7-8, 2017 Vienna, Austria; The International Liver Congress, April 19-23, 2017 Amsterdam, Netherlands;  6th Asian Conference on Hepatitis and AIDS, May 20-21, 2017 Tianjin, China; 15th European Meeting on HIV & Hepatitis – Treatment Strategies & Antiviral Drug Resistance, June 7-9, 2017 Rome, Italy; 3rd Central & Eastern Meeting on Viral Hepatitis and Co-infection with HIV, October 6-7, 2017 Bucharest, Romania; World Congress on Gastroenterology, October 13-18, 2017 Florida, USA; International HBV Cure Workshop, November 10, 2017 Toronto, Canada; 4th International Meeting on Elimination of Viral Hepatitis, December 1-2, 2017 Amsterdam, Netherlands; American Association for the Study of Liver DiseasesAmerican Hepato-Pancreato-Biliary AssociationAmerican Liver FoundationEuropean Association for the Study of the LiverAsian Pacific Association for the Study of the LiverInternational Association for the Study of the LiverBritish Association for the Study of the LiverCanadian Association for the Study of the LiverCanadian Liver FoundationChildren's Liver Disease FoundationEuroliver FoundationHepatitis B FoundationHepatitis Foundation InternationalInternational Liver Transplantation SocietyInternational Hepato Pancreato Biliary Association
 

Track 6: Liver Diseases Diagnosis

Screening for Liver diseases has been advocated with the intention of intervening to halt its progression. Abnormal liver tests are those that measure synthesis of proteins made by the liver (albumin, clotting factors) or the liver's capacity to metabolize drugs. The impact of diagnosis of hepatitis C virus on quality of life is worse in patients aware of their viral status compared with individuals unaware of their viral status.

Related  Hepatitis Conferences | Liver Conferences | Conference Series LLC: International Conference on Pancreatic Disorders and Treatment, October 17-19, 2016 Chicago, USA; 9 th Euro-Global Gastroenterology Conference, October 24-25, 2016 Valencia, Spain; International Conference on Digestive Diseases, December 08-09, 2016 Dubai, UAE; 4th International Conference on Hepatology, April 27-29, 2017 Dubai, UAE; 11th Global Gastroenterologists Meeting, June 12-13, 2017 Rome, Italy; 5th World Congress on Hepatitis & Liver Diseases, August 10-12, 2017 London, UK; 13th International Conference on Clinical Gastroenterology and Hepatology, November 13-15, 2017 Las Vegas, USA; Asian Pacific Digestive Week, November 02-05, 2016 Kobe, Japan; Japan Digestive Disease Week, November 03-06, 2016 Kobe, Japan; Seoul International Digestive Disease Symposium, November 24-25, 2016 South Korea; 57th Annual Conference of Indian Society of Gastroenterology, December 15-18, 2016 New Delhi, India; Gastrointestinal Cancers Symposium, January 19 – 21, 2017 San Francisco, USA;  Institute of Liver Diseases and Transplantation, January 20-22, 2017 Tamil Nadu, India; 10th Paris Hepatitis Conference, January 30-31, 2017 Paris, France; EASL HCC Summit, February 2-5, 2017 Geneva, Switzerland; EASL Liver Immunology, February 16-18, 2017 Aachen, Germany; Asian Pacific Association for the Study of the Liver, February 16-19, 2017 Shanghai, China; 6th Canadian Symposium on HCV, March 03, 2017 Banff, Canada; 17th Annual Gastroenterology and Hepatology, March 7-10, 2017 San Juan, Puerto Rico; Mayo Clinic Gastroenterology and Hepatology, March 16-19 2017 Orlando, USA; World Hepatitis Summit, March 29-31, 2017 São Paulo, Brazil; Congress of the Italian Society of Digestive Diseases, March 29-April 1, 2017 Bologna, Italy; World Congress of the International Hepato-Pancreato-Biliary Association, March 29-April 2, 2017 Miami, USA; European Gastro Update, April 7-8, 2017 Vienna, Austria; The International Liver Congress, April 19-23, 2017 Amsterdam, Netherlands;  6th Asian Conference on Hepatitis and AIDS, May 20-21, 2017 Tianjin, China; 15th European Meeting on HIV & Hepatitis – Treatment Strategies & Antiviral Drug Resistance, June 7-9, 2017 Rome, Italy; 3rd Central & Eastern Meeting on Viral Hepatitis and Co-infection with HIV, October 6-7, 2017 Bucharest, Romania; World Congress on Gastroenterology, October 13-18, 2017 Florida, USA; International HBV Cure Workshop, November 10, 2017 Toronto, Canada; 4th International Meeting on Elimination of Viral Hepatitis, December 1-2, 2017 Amsterdam, Netherlands; American Association for the Study of Liver DiseasesAmerican Hepato-Pancreato-Biliary AssociationAmerican Liver FoundationEuropean Association for the Study of the LiverAsian Pacific Association for the Study of the LiverInternational Association for the Study of the LiverBritish Association for the Study of the LiverCanadian Association for the Study of the LiverCanadian Liver FoundationChildren's Liver Disease FoundationEuroliver FoundationHepatitis B FoundationHepatitis Foundation InternationalInternational Liver Transplantation SocietyInternational Hepato Pancreato Biliary Association
 

Track 7: Liver Diseases

Liver is responsible for many critical functions within the body. It helps your body digest food, store energy, and remove poisons. If it becomes diseased or injured, the loss of those functions can cause significant damage to the body. There are over 100 different forms of liver disease that affect men, women and children. These diseases include cirrhosis, alcohol abuse, hepatitis A, B, C, D, and E, Epstein Barr virus (infectious mononucleosis), non-alcoholic fatty liver disease and iron overload (hemochromatosis). The main symptoms of liver imbalance include weakness and fatigue, weight loss, nausea, vomiting, and yellow discoloration of the skin (jaundice).

Related  Hepatitis Conferences | Liver Conferences | Conference Series LLC: International Conference on Pancreatic Disorders and Treatment, October 17-19, 2016 Chicago, USA; 9 th Euro-Global Gastroenterology Conference, October 24-25, 2016 Valencia, Spain; International Conference on Digestive Diseases, December 08-09, 2016 Dubai, UAE; 4th International Conference on Hepatology, April 27-29, 2017 Dubai, UAE; 11th Global Gastroenterologists Meeting, June 12-13, 2017 Rome, Italy; 5th World Congress on Hepatitis & Liver Diseases, August 10-12, 2017 London, UK; 13th International Conference on Clinical Gastroenterology and Hepatology, November 13-15, 2017 Las Vegas, USA; Asian Pacific Digestive Week, November 02-05, 2016 Kobe, Japan; Japan Digestive Disease Week, November 03-06, 2016 Kobe, Japan; Seoul International Digestive Disease Symposium, November 24-25, 2016 South Korea; 57th Annual Conference of Indian Society of Gastroenterology, December 15-18, 2016 New Delhi, India; Gastrointestinal Cancers Symposium, January 19 – 21, 2017 San Francisco, USA;  Institute of Liver Diseases and Transplantation, January 20-22, 2017 Tamil Nadu, India; 10th Paris Hepatitis Conference, January 30-31, 2017 Paris, France; EASL HCC Summit, February 2-5, 2017 Geneva, Switzerland; EASL Liver Immunology, February 16-18, 2017 Aachen, Germany; Asian Pacific Association for the Study of the Liver, February 16-19, 2017 Shanghai, China; 6th Canadian Symposium on HCV, March 03, 2017 Banff, Canada; 17th Annual Gastroenterology and Hepatology, March 7-10, 2017 San Juan, Puerto Rico; Mayo Clinic Gastroenterology and Hepatology, March 16-19 2017 Orlando, USA; World Hepatitis Summit, March 29-31, 2017 São Paulo, Brazil; Congress of the Italian Society of Digestive Diseases, March 29-April 1, 2017 Bologna, Italy; World Congress of the International Hepato-Pancreato-Biliary Association, March 29-April 2, 2017 Miami, USA; European Gastro Update, April 7-8, 2017 Vienna, Austria; The International Liver Congress, April 19-23, 2017 Amsterdam, Netherlands;  6th Asian Conference on Hepatitis and AIDS, May 20-21, 2017 Tianjin, China; 15th European Meeting on HIV & Hepatitis – Treatment Strategies & Antiviral Drug Resistance, June 7-9, 2017 Rome, Italy; 3rd Central & Eastern Meeting on Viral Hepatitis and Co-infection with HIV, October 6-7, 2017 Bucharest, Romania; World Congress on Gastroenterology, October 13-18, 2017 Florida, USA; International HBV Cure Workshop, November 10, 2017 Toronto, Canada; 4th International Meeting on Elimination of Viral Hepatitis, December 1-2, 2017 Amsterdam, Netherlands; American Association for the Study of Liver DiseasesAmerican Hepato-Pancreato-Biliary AssociationAmerican Liver FoundationEuropean Association for the Study of the LiverAsian Pacific Association for the Study of the LiverInternational Association for the Study of the LiverBritish Association for the Study of the LiverCanadian Association for the Study of the LiverCanadian Liver FoundationChildren's Liver Disease FoundationEuroliver FoundationHepatitis B FoundationHepatitis Foundation InternationalInternational Liver Transplantation SocietyInternational Hepato Pancreato Biliary Association
 

Track 8: Pregnancy and Liver Diseases

Several disorders contribute to liver disease in pregnancy such as acute fatty liver of pregnancy (AFLP) and intrahepatic cholestasis of pregnancy (IHCP), hyperemesis gravidarum and hemolysis and elevated liver enzymes and low platelets (HELLP) syndrome. Liver disease such as acute viral hepatitis can occur in pregnancy and pregnancy may occur in a patient with underlying chronic liver disease including patients with cirrhosis and portal hypertension, and patients who have undergone liver transplantation.

Related  Hepatitis Conferences | Liver Conferences | Conference Series LLC: International Conference on Pancreatic Disorders and Treatment, October 17-19, 2016 Chicago, USA; 9 th Euro-Global Gastroenterology Conference, October 24-25, 2016 Valencia, Spain; International Conference on Digestive Diseases, December 08-09, 2016 Dubai, UAE; 4th International Conference on Hepatology, April 27-29, 2017 Dubai, UAE; 11th Global Gastroenterologists Meeting, June 12-13, 2017 Rome, Italy; 5th World Congress on Hepatitis & Liver Diseases, August 10-12, 2017 London, UK; 13th International Conference on Clinical Gastroenterology and Hepatology, November 13-15, 2017 Las Vegas, USA; Asian Pacific Digestive Week, November 02-05, 2016 Kobe, Japan; Japan Digestive Disease Week, November 03-06, 2016 Kobe, Japan; Seoul International Digestive Disease Symposium, November 24-25, 2016 South Korea; 57th Annual Conference of Indian Society of Gastroenterology, December 15-18, 2016 New Delhi, India; Gastrointestinal Cancers Symposium, January 19 – 21, 2017 San Francisco, USA;  Institute of Liver Diseases and Transplantation, January 20-22, 2017 Tamil Nadu, India; 10th Paris Hepatitis Conference, January 30-31, 2017 Paris, France; EASL HCC Summit, February 2-5, 2017 Geneva, Switzerland; EASL Liver Immunology, February 16-18, 2017 Aachen, Germany; Asian Pacific Association for the Study of the Liver, February 16-19, 2017 Shanghai, China; 6th Canadian Symposium on HCV, March 03, 2017 Banff, Canada; 17th Annual Gastroenterology and Hepatology, March 7-10, 2017 San Juan, Puerto Rico; Mayo Clinic Gastroenterology and Hepatology, March 16-19 2017 Orlando, USA; World Hepatitis Summit, March 29-31, 2017 São Paulo, Brazil; Congress of the Italian Society of Digestive Diseases, March 29-April 1, 2017 Bologna, Italy; World Congress of the International Hepato-Pancreato-Biliary Association, March 29-April 2, 2017 Miami, USA; European Gastro Update, April 7-8, 2017 Vienna, Austria; The International Liver Congress, April 19-23, 2017 Amsterdam, Netherlands;  6th Asian Conference on Hepatitis and AIDS, May 20-21, 2017 Tianjin, China; 15th European Meeting on HIV & Hepatitis – Treatment Strategies & Antiviral Drug Resistance, June 7-9, 2017 Rome, Italy; 3rd Central & Eastern Meeting on Viral Hepatitis and Co-infection with HIV, October 6-7, 2017 Bucharest, Romania; World Congress on Gastroenterology, October 13-18, 2017 Florida, USA; International HBV Cure Workshop, November 10, 2017 Toronto, Canada; 4th International Meeting on Elimination of Viral Hepatitis, December 1-2, 2017 Amsterdam, Netherlands; American Association for the Study of Liver DiseasesAmerican Hepato-Pancreato-Biliary AssociationAmerican Liver FoundationEuropean Association for the Study of the LiverAsian Pacific Association for the Study of the LiverInternational Association for the Study of the LiverBritish Association for the Study of the LiverCanadian Association for the Study of the LiverCanadian Liver FoundationChildren's Liver Disease FoundationEuroliver FoundationHepatitis B FoundationHepatitis Foundation InternationalInternational Liver Transplantation SocietyInternational Hepato Pancreato Biliary Association
 

Track 9: Liver Transplantation and Surgery

Liver transplantation surgery technique to replace a diseased or injured liver with a healthy liver delivered from a healthy person. The liver is involved in various metabolic functioning including metabolism of drugs and toxins, removing degradation products of normal body metabolism (for example clearance of ammonia and bilirubin from the blood), and synthesis of many important proteins and enzymes (such as factors necessary for blood to clot). Doctors or surgeons suggest liver transplant surgery to the patients who suffer from severe Drug-induced liver injury (DILI) or Chronic liver failure. This surgery carries a risk of other complications including infection, liver inflammation, blood clots, liver rejection, memory and thinking problems.

Related  Hepatitis Conferences | Liver Conferences | Conference Series LLC: International Conference on Pancreatic Disorders and Treatment, October 17-19, 2016 Chicago, USA; 9 th Euro-Global Gastroenterology Conference, October 24-25, 2016 Valencia, Spain; International Conference on Digestive Diseases, December 08-09, 2016 Dubai, UAE; 4th International Conference on Hepatology, April 27-29, 2017 Dubai, UAE; 11th Global Gastroenterologists Meeting, June 12-13, 2017 Rome, Italy; 5th World Congress on Hepatitis & Liver Diseases, August 10-12, 2017 London, UK; 13th International Conference on Clinical Gastroenterology and Hepatology, November 13-15, 2017 Las Vegas, USA; Asian Pacific Digestive Week, November 02-05, 2016 Kobe, Japan; Japan Digestive Disease Week, November 03-06, 2016 Kobe, Japan; Seoul International Digestive Disease Symposium, November 24-25, 2016 South Korea; 57th Annual Conference of Indian Society of Gastroenterology, December 15-18, 2016 New Delhi, India; Gastrointestinal Cancers Symposium, January 19 – 21, 2017 San Francisco, USA;  Institute of Liver Diseases and Transplantation, January 20-22, 2017 Tamil Nadu, India; 10th Paris Hepatitis Conference, January 30-31, 2017 Paris, France; EASL HCC Summit, February 2-5, 2017 Geneva, Switzerland; EASL Liver Immunology, February 16-18, 2017 Aachen, Germany; Asian Pacific Association for the Study of the Liver, February 16-19, 2017 Shanghai, China; 6th Canadian Symposium on HCV, March 03, 2017 Banff, Canada; 17th Annual Gastroenterology and Hepatology, March 7-10, 2017 San Juan, Puerto Rico; Mayo Clinic Gastroenterology and Hepatology, March 16-19 2017 Orlando, USA; World Hepatitis Summit, March 29-31, 2017 São Paulo, Brazil; Congress of the Italian Society of Digestive Diseases, March 29-April 1, 2017 Bologna, Italy; World Congress of the International Hepato-Pancreato-Biliary Association, March 29-April 2, 2017 Miami, USA; European Gastro Update, April 7-8, 2017 Vienna, Austria; The International Liver Congress, April 19-23, 2017 Amsterdam, Netherlands;  6th Asian Conference on Hepatitis and AIDS, May 20-21, 2017 Tianjin, China; 15th European Meeting on HIV & Hepatitis – Treatment Strategies & Antiviral Drug Resistance, June 7-9, 2017 Rome, Italy; 3rd Central & Eastern Meeting on Viral Hepatitis and Co-infection with HIV, October 6-7, 2017 Bucharest, Romania; World Congress on Gastroenterology, October 13-18, 2017 Florida, USA; International HBV Cure Workshop, November 10, 2017 Toronto, Canada; 4th International Meeting on Elimination of Viral Hepatitis, December 1-2, 2017 Amsterdam, Netherlands; American Association for the Study of Liver DiseasesAmerican Hepato-Pancreato-Biliary AssociationAmerican Liver FoundationEuropean Association for the Study of the LiverAsian Pacific Association for the Study of the LiverInternational Association for the Study of the LiverBritish Association for the Study of the LiverCanadian Association for the Study of the LiverCanadian Liver FoundationChildren's Liver Disease FoundationEuroliver FoundationHepatitis B FoundationHepatitis Foundation InternationalInternational Liver Transplantation SocietyInternational Hepato Pancreato Biliary Association
 

Track 10: HCV/HIV Coinfection

Overall, about one-third of people with HIV also have hepatitis C. Hepatitis C virus (HCV) can be transmitted in some of the same ways as HIV and hepatitis B. HIV can worsen hepatitis C. HIV not only increase the risk of liver damage, but it can also speed up the onset of liver damage following infection. People who are coinfected with HIV and HCV should work closely with health care providers in order to monitor and treat both conditions.

Related  Hepatitis Conferences | Liver Conferences | Conference Series LLC: International Conference on Pancreatic Disorders and Treatment, October 17-19, 2016 Chicago, USA; 9 th Euro-Global Gastroenterology Conference, October 24-25, 2016 Valencia, Spain; International Conference on Digestive Diseases, December 08-09, 2016 Dubai, UAE; 4th International Conference on Hepatology, April 27-29, 2017 Dubai, UAE; 11th Global Gastroenterologists Meeting, June 12-13, 2017 Rome, Italy; 5th World Congress on Hepatitis & Liver Diseases, August 10-12, 2017 London, UK; 13th International Conference on Clinical Gastroenterology and Hepatology, November 13-15, 2017 Las Vegas, USA; Asian Pacific Digestive Week, November 02-05, 2016 Kobe, Japan; Japan Digestive Disease Week, November 03-06, 2016 Kobe, Japan; Seoul International Digestive Disease Symposium, November 24-25, 2016 South Korea; 57th Annual Conference of Indian Society of Gastroenterology, December 15-18, 2016 New Delhi, India; Gastrointestinal Cancers Symposium, January 19 – 21, 2017 San Francisco, USA;  Institute of Liver Diseases and Transplantation, January 20-22, 2017 Tamil Nadu, India; 10th Paris Hepatitis Conference, January 30-31, 2017 Paris, France; EASL HCC Summit, February 2-5, 2017 Geneva, Switzerland; EASL Liver Immunology, February 16-18, 2017 Aachen, Germany; Asian Pacific Association for the Study of the Liver, February 16-19, 2017 Shanghai, China; 6th Canadian Symposium on HCV, March 03, 2017 Banff, Canada; 17th Annual Gastroenterology and Hepatology, March 7-10, 2017 San Juan, Puerto Rico; Mayo Clinic Gastroenterology and Hepatology, March 16-19 2017 Orlando, USA; World Hepatitis Summit, March 29-31, 2017 São Paulo, Brazil; Congress of the Italian Society of Digestive Diseases, March 29-April 1, 2017 Bologna, Italy; World Congress of the International Hepato-Pancreato-Biliary Association, March 29-April 2, 2017 Miami, USA; European Gastro Update, April 7-8, 2017 Vienna, Austria; The International Liver Congress, April 19-23, 2017 Amsterdam, Netherlands;  6th Asian Conference on Hepatitis and AIDS, May 20-21, 2017 Tianjin, China; 15th European Meeting on HIV & Hepatitis – Treatment Strategies & Antiviral Drug Resistance, June 7-9, 2017 Rome, Italy; 3rd Central & Eastern Meeting on Viral Hepatitis and Co-infection with HIV, October 6-7, 2017 Bucharest, Romania; World Congress on Gastroenterology, October 13-18, 2017 Florida, USA; International HBV Cure Workshop, November 10, 2017 Toronto, Canada; 4th International Meeting on Elimination of Viral Hepatitis, December 1-2, 2017 Amsterdam, Netherlands; American Association for the Study of Liver DiseasesAmerican Hepato-Pancreato-Biliary AssociationAmerican Liver FoundationEuropean Association for the Study of the LiverAsian Pacific Association for the Study of the LiverInternational Association for the Study of the LiverBritish Association for the Study of the LiverCanadian Association for the Study of the LiverCanadian Liver FoundationChildren's Liver Disease FoundationEuroliver FoundationHepatitis B FoundationHepatitis Foundation InternationalInternational Liver Transplantation SocietyInternational Hepato Pancreato Biliary Association
 





About Conference

Conference Series invites you to attend 5th World Congress on Hepatitis and Liver diseases (Hepatitis 2017) to be held in London, UK during August 10-12, 2017. The conference highlights the theme “Early diagnosis, treatment of viral hepatitis and optimizing therapy costs”.

Conference Series organizes 300+ International Conferences Every Year across USA, Europe & Asia with support from 1000 more scientific Societies and publishes 400+ Open Access Journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.

Hepatitis 2017 is a best platform with its well organized scientific program to the audience which includes symposiums, workshops, keynote lectures, plenary talks, panel discussions and poster sessions on latest research and technological developments in the arena as well as therapeutic aspects. The conference invites Hepatologists, Gastroenterologists, Internists, Physicians, Microbiologists, Virologists, Pathologists, Oncologists, Surgeons, Toxicologists, Researchers, Students, Business delegates and Young researchers across the globe.

Conference Opportunities

For Researchers and Faculty Members:

Speaker Presentations
Poster Display
Symposium hosting (4-5 member team)
Workshop organizing

For Universities, Associations & Societies:

Association Partnering
Collaboration proposals
Academic Partnering
Group Participation

For Students and Research Scholars:

Poster Competition (Winner will get Best Poster Award)
Young Researcher Forum (YRF Award to the best presenter)
Student Attendee
Group registrations

For Business Delegates:

Speaker Presentations
Symposium hosting
Book Launch event
Networking opportunities
Audience participation

For Product Manufacturers:

Exhibitor and Vendor booths
Sponsorships opportunities
Product launch
Workshop organizing
Scientific Partnering
Marketing and Networking with clients

 





Market Analysis

Hepatitis is an inflammatory condition of the liver caused by the hepatitis virus. The most observed types of this disease are hepatitis A, hepatitis B and hepatitis C. Globally, 350 million people are chronically infected with any one form of hepatitis and around 500,000 people die every year according to World Health Organization. Hepatitis A is a simpler form of which does not lead to chronic infections. Patients suffering from hepatitis A recover within two months as this form is less complicated and can be prevented with vaccination. Although hepatitis B can be prevented by vaccination, once infected, a person can develop lifelong chronic infection resulting into severe liver damage. More than 2 billion people of the global population are infected with hepatitis B. Hepatitis B patients are vulnerable to further complications related to the liver, such as: hepatocellular carcinoma (liver cancer), liver failure, and liver cirrhosis.

Hepatitis C is most dangerous of among all the types of hepatitis as 80% of the hepatitis C infected patients get chronically infected. Around 150 million people are infected with hepatitis C worldwide and 350,000 people die every year. It has a cure rate of less than 80%, which drops below 60% in some regions of the world. The low cure rate is supplemented in most regions by a lack of an effective vaccine against hepatitis C. The global hepatitis C market is thus growing in response. Recent estimates find that about 215,000 people in the UK are chronically infected with hepatitis C.

In the United States, 20 percent to 30 percent of people living with HIV are coinfected with HCV. Hepatitis C is common among people living with HIV. This means that about 225,000 to 330,000 people in the United States are living with both viruses. The majority of people living with hepatitis C do not know they have it. The most common route of transmission in the UK is using non-sterile needles and other equipment for injecting drugs. 90 percent of people who got HIV from injecting drugs are also infected with HCV. This is because both viruses can be spread easily through blood and blood products.

Scope of the Conference

Hepatitis 2017 provides a great platform by gathering eminent professors, Researchers, Students and delegates to exchange new ideas.  The conference will cover a wide range of topics and allow participants to discuss about the management of liver diseases. Hepatitis 2017 conference consists of keynote and plenary lectures, special sessions (Workshop and Symposium), Young Researcher Forum and Poster presentations. Best poster presenters will be judged and awarded during the conference. To encourage broad participation from all over the world Conference Series LLC is offering reduced registration fee for students.

Medical Colleges in UK

  • Imperial College London
  • University College London
  • King's College London
  • Queen Mary University of London
  • St. George’s, University of London
  • The University of Buckingham
  • University of Oxford
  • University of Cambridge
  • University of Southampton
  • Hull York Medical School
  • Cardiff University School of Medicine
  • Keele University School of Medicine
  • University of Glasgow
  • Warwick Medical School
  • Brighton and Sussex Medical School
  • Norwich Medical School
  • University of Aberdeen
  • Leicester Medical School
  • Swansea University Medical School
  • The University of Sheffield
  • University of St Andrews School of Medicine
  • University of Birmingham Medical School
  • Leeds School of Medicine
  • University of Edinburgh Medical School
  • Lancaster Medical School

Pharmaceutical Industries in the UK

  • Abbot Laboratories
  • Adaptimmune
  • Allergan
  • Alnylam Pharmaceuticals
  • AstraZeneca
  • Bausch & Lomb
  • Bayer
  • BioMarin Pharmaceuticals
  • Biota Pharmaceuticals
  • Bristol-Myers Squib
  • Cellular Therapeutics
  • ChemOvation
  • Chroma Therapeutics
  • Chronos Therapeutics
  • Chugai Pharma UK Ltd
  • Clovis Oncology
  • Convergence Pharmaceuticals
  • Cyclacel Pharmaceuticals
  • Daiichi Sankyo
  • Eli Lilly and Company
  • Enigma Diagnostics
  • Glaxo SmithKline
  • Immunocore
  • Innova Biosciences
  • IOmet Pharma
  • Karus Therapeutics
  • Martindale Pharma
  • MISSION Therapeutics
  • Morningside Pharmaceuticals Ltd
  • Napp Pharmaceutical
  • Novartis
  • Novo Nordisk
  • Novus Biologicals
  • Oxford BioTherapeutics
  • Par Pharmaceuticals
  • Pfizer
  • Pharminox
  • ProMetic Life Sciences
  • Roche
  • Roche
  • Servier
  • Shield Therapeutics
  • Shire Pharmaceuticals Limited
  • Silence Therapeutics
  • Vantia Therapeutics
  • Vernalis
  • Vernalis

Liver Associations

  • European Association for the Study of the Liver (EASL)
  • Euroliver Foundation
  • British Association for the Study of the Liver (BASL)
  • British Liver Trust - National charity for adult liver disease
  • American Association for the Study of Liver Diseases (AASLD)
  • American Hepato-Pancreato-Biliary Association (AHPBA)
  •  American Liver Foundation (ALF)           
  • Texas Society for Gastroenterology and Endoscopy
  • International Hepato Pancreato Biliary Association (IHPBA)
  • Canadian Association for the Study of the Liver (CASL) - Canada (CA)
  • Canadian Liver Foundation (CLF) - Canada (CA)
  • Latin American Association for the Study of the Liver (ALEH)
  • International Association for the Study of the Liver (IASL)
  • Childhood Liver Tumour Study Group (SIOPEL) 
  • Liver Kids Australia
  • Children's Liver Disease Foundation (CLDF)
  • Hepatitis B Foundation
  • Hepatitis Foundation International          
  • Asian Pacific Association for the Study of the Liver (APASL)
  • Hong Kong Liver Foundation - Hong Kong (HK), China
  • Immunization Action Coalition
  • International Liver Transplantation Society (ILTS)
  • Swiss Association for the Study of the Liver (SASL) - Switzerland (CH)

Approved treatments for Hepatitis

  • Epclusa
  • Zepatier
  • Daklinza
  • Technivie
  • VIEKIRA PAK
  • VIEKIRA XR
  • Harvoni
  • Sovaldi
  • Olysio
  • Incivek
  • Victrelis
  • Pegasys
  • Pegintron
  • Rebetol
  • Infergen

FDA approved drugs in 2016 for Hepatology

  • Defitelio
  • Ocaliva

Companies manufacturing Liver equipment’s

  • Echosens
  • KMC Systems
  • Argon Medical devices Inc
  • Humedics




Past Conference Report

Hepatitis 2016

3rd World Congress on Hepatitis and Liver Diseases (Hepatitis-2016) organised by Conference Series was held on October 10-12, 2016 at JW Marriott Dubai, UAE. The conference highlighted the theme, “Treatment and Management strategies to eradicate Hepatitis and Liver diseases”. It is an annual meeting for the study of recent advancements and management of Hepatitis and Liver diseases.

The conference was initiated with a warm welcome note from Honorable guests and our special thanks to Dr. Arnolfo Petruzziello, National Cancer Institute, IRCCS Fondazione G. Pascale, Italy the Honorable Moderator for the conference who contributed a major part for the success of this event. The conference was marked with the presence of renowned scientists, talented young researchers, students and business delegates driving the three days event into the path of success with thought provoking keynote and plenary presentations. Active participation and generous response were received from the Organizing Committee Members. Professors, Researchers, and Students from diverse groups made this conference as one of the most successful and productive event in 2016 from Conference Series.

The highlights of the meeting were the enlightening keynote lectures from:

  • Andrew Vaillant, Replicor Inc, Canada on the topic, “Nucleic Acid Polymers:  broad spectrum antiviral agents and their development as the backbone of new
  • antiviral therapies for the treatment of chronic HBV and HBV / HDV infection”.
  • Arnolfo Petruzziello, National Cancer Institute, IRCCS Fondazione G. Pascale, Italy on the topic, “Hepatitis C virus (HCV) infection: A global epidemiology up-date of the circulation of HCV genotypes”.
  • Alaaeldin Ibrahim, ACDS, UAE on the topic, “Sepsis in Cirrhotics”.

The conference proceedings were carried out through various scientific sessions and plenary lectures:

  • Title: Direct-acting antivirals Ombitasvir/Paritaprevir/Ritonavir+Dasabuvir with or without Ribavirin in HCV genotype 1-infected treatment-naive or treatment-experienced patients with or without cirrhosis by Ligita Jancoriene, Vilnius University Hospital, Lithuania.
  • Title: Current therapeutic approaches to NAFLD treatment presented by Asad I Dajani, Arab Doctors Specialist, UAE.
  • Title: Hepatitis B revaccination to students whom firstly demonstrated anti-HBs negative or titer <10 mIU/ml presented by Prapan Jutavijittum, Chiang Mai University, Thailand.
  • Title: Therapeutic trial to assess the efficacy and safety of folic acid and/or vitamin B complex on hepatitis C infected patients treated with pegylated interferon and ribavirin lectured by Nermeen Nabil Ashoush, The British University in Egypt, Egypt.
  • Title: Circulating microRNAs as non-invasive biomarkers for the detection of different stages of liver fibrosis in Egyptian HCV patients delivered by Eman El-Ahwany, Theodor Bilharz Research Institute, Egypt.
  • Title: Treating patients with hepatitis C genotype 1 using Viekira Pak™ in the real world: An Australian nursing perspective given by Vince Fragomeli, Nepean Hospital, Australia.
  • Title: 40 years observation in Liver diseases in the Middle East presented by Makki H Fayadh, ACDS, UAE.
  • Title: Genetics in hepatitis B shared by Osama Hasan Othman, University of Kirkuk, Iraq.
  • Title: Matrine eliminates hepatosteatosis and glucose intolerance in high fructose-fed mice by suppressing ER stress associated de novo lipogenesis in the liver lectured by Ali Mahzari, RMIT University, Australia.
  • Title: We can beat the frightening ghost, HCC shared by Medhat El-Hosary, Kafr elsheikh Liver Research Center, Egypt.

Conference Series has taken the privilege of felicitating Hepatitis 2016 Organizing Committee and Keynote Speakers who supported and contributed for the success of this event. Conference Series, congratulate the Best Poster awardee Andreas Christe, University Hospital of Bern, Switzerland and Makki H Fayadh, ACDS, UAE.

We are glad to inform that all accepted abstracts for the conference have been indexed in Conference Series Journal, Journal of Liver as a special issue.

We sincerely thank the Organizing Committee Members, Participants and Media Partners for their gracious presence and generous support, without which the conference would not have reached the pinnacle of success. With the unique feedback from the conference, Conference Series would like to announce the commencement of the “5th  World Congress on Hepatitis and Liver Diseases” during August 10-12, 2017 in London, UK.

Let us meet again @ Hepatitis 2017

Hepatitis 2015

OMICS International takes a great pride in announcing the commencement of "World Congress on Hepatitis” during July 20-22, 2015 at Hyatt Regency Orlando International Airport, Florida, USA. The conference highlights the theme “Raising global awareness on hepatitis and fighting the stigma surrounding the disease”. It is the annual meeting for the study of Hepatitis.

With the support and contribution of the organizing committee members, we successfully hosted an event at the conference venue. Active participation and generous response were received from the Organizing Committee Members, Editorial Board Members of OMICS Group Journals, Professors, Researchers, Experts and Students from diverse groups who made this conference as one of the most successful and productive event in 2015 from OMICS International. The conference was marked with the attendance of young researchers, business delegates and students who have driven this event into the path of success.  

The conference was initiated with a warm welcome note from Honorable guests and the Keynote forum lead by Dr. Mark A Feitelson, Associate Director, Temple University, USA. The proceedings went through interactive sessions and panel discussions headed by Dr. Trent W Nichols, AMRI, USA, an honorable Moderator for the conference, who contributed a major part for the success of this event.

The conference witnessed an amalgamation of peerless speakers, who enlightened the crowd with their enviable research knowledge and on various alluring topics related to the field of hepatitis, carried out through various scientific-sessions and plenary lectures:

  • Does the hepatitis B antigen HBx promote the appearance of liver cancer stem cells? -Dr. Mark A Feitelson, Temple University, USA
  • The Growing Epidemic in HCC from Hepatitis/NASH Cirrhosis in American Veterans-Dr. Trent W Nichols, AMRI, USA
  • Lower GI Bleeding in Patients with cirrhosis- Dr. Maxwell M Chait, Columbia University, USA
  • Impacts of platelets on the prognosis of patients with hepatocellular carcinoma– Dr. Sen-Yung Hsieh, Chang Gung Memorial Hospital, Taiwan

Also, the conference proceeding was encouraged through the wonderful symposiums by Dr. Andre Jean Remy, Perpignan Hospital, France, on the title ” New tools of screening viral hepatitis in real life: The French model of care and by Dr. Ehab Abd-El-Atty, Menoufia University, Egypt, on the title “HCC risk factors synergism in Egypt and how to prevent?”

A workshop session was done on “The Cirrhosis Micro-environment and Hepato-carcinogenesis” by Dr. Sen-Yung Hsieh, Chang Gung Memorial Hospital, Taiwan.

OMICS International has taken the privilege of felicitating Hepatitis-2015 Organizing Committee, Editorial Board Members and Keynote Speakers who supported for the success of this event. OMICS International, on behalf of the conference exhibitor congratulate the Best Poster awardee for her outstanding performance in the field of Hepatocellular carcinoma and appreciates all the participants who put their efforts in poster presentations and sincerely wishes them success in future endeavors. 

We are glad to inform that all accepted abstracts for the conference have been indexed in OMICS Journal of Liver and Journal of Liver Disease and Transplantation as a special issue.

We sincerely thank the Organizing Committee Members, Editorial Board Members of OMICS Journals, Participants, Attendees, Sponsors, Exhibitors, and Media partners for their gracious presence and generous support, without which the conference would not have been possible. With the unique feedback from the conference, OMICS International would like to announce the commencement of the "2nd International Conference on Hepatology” May 9-11, 2016 in Chicago, USA and “3rd World Congress on Hepatitis and Liver Diseases" October 17-19, 2016 in Dubai, UAE.

 

Let us meet again @ 2016 Conferences

 


Past Reports  Gallery  



Click here to submit abstract to any of the above topics

sponsor

Want to Differentiate your company from your competitors and broaden your competitive edge?

Use our global platform of 3000+ Global Events

  • 25 Million+ Visitors to our Global website (conferenceseries.com)
  • 20000+ Unique Visitors per conference
  • 60000+ Page views per conference

For customized sponsorship opportunities at our conferences, or to place an ad on our websites, contact at sponsors@conferenceseries.com or call at: +1-650-268-9744

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date August 10-12, 2017
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Day 1 Day 2 Day 3
Poster Opportunity Available

Conferenceseries Destinations